Clinical trials recruiting in Funchal, Portugal
4
Recruiting trials
7
Conditions
Phase breakdown
Phase 3 4
Conditions recruiting in Funchal, Portugal
| Condition | Trials |
|---|---|
| Advanced (Unresectable or Metastatic) Melanoma | 1 |
| Chronic kidney disease | 1 |
| Kidney Disease, Chronic | 1 |
| Lung cancer | 1 |
| Melanoma | 1 |
| Non-small Cell Lung Cancer (NSCLC) | 1 |
| Parkinson's Disease | 1 |
Recruiting trials in Funchal, Portugal
- A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
- Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma
Common questions
How many clinical trials are recruiting in Funchal, Portugal?
4 recruiting trials have at least one study site in Funchal, Portugal.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.